13348-41-9Relevant academic research and scientific papers
The reductive amination of cyclohexanone with 1,6-diaminohexane over alumina B modified Cu-Cr-La/γ-Al2O3
Sun, Meng,Du, Xiaobao,Kong, Xiangjin,Lu, Liang,Li, Yang,Chen, Ligong
experimental part, p. 58 - 62 (2012/06/16)
The reductive amination of cyclohexanone with 1,6-diaminohexane over alumina B modified Cu-Cr-La/γ-Al2O3 was investigated. The experimental results indicated that the doped alumina B remarkably increased the selectivity of N, N′-dicy
CHAIN EXTENDERS
-
Page/Page column 13, (2008/12/08)
This invention provides chain extender compositions. These compositions comprise aliphatic secondary diamines in which the amino hydrocarbyl groups are different from each other. Processes for producing polyurethanes, polyureas, and polyurea-urethanes using these aliphatic secondary diamines are also provided.
PREPARATION OF SECONDARY DIAMINES
-
Page/Page column 10, (2008/12/07)
This invention provides a process for forming secondary diamines. The process comprises bringing together i) at least one aliphatic cyclic ketone, ii) at least one aliphatic primary diamine, iii) hydrogen, and iv) a hydrogenation catalyst. The aliphatic primary diamine is isophoronediamine or an aliphatic primary α,ω-diamine, and the hydrogenation catalyst is selected from platinum on carbon, palladium on carbon, sulfided platinum on carbon, sulfided palladium on carbon, and a mixture of any two of the foregoing. The process is conducted at a temperature in the range of about 200C to about 750C and at a hydrogen pressure in the range of about 1 to about 95 pounds per square inch gauge, such that a secondary diamine is formed.
Allosteric modulators of the tertiary alkanebisamino-type. Variation of the substitution of the middle chain nitrogens
Pick, Rainer,Duda-Johner, Seraina,Traenkle, Christian,Mohr, Klaus,Holzgrabe, Ulrike
, p. 1539 - 1556 (2007/10/03)
Synthesis pathways of high flexibility for variously substituted alkanebisamine-type allosteric modulators of muscarinic receptors capable of passing the blood-brain barrier were developed starting either from N,N′-(hexane-1,6-diyl)bistosylamide or adipic
